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ABSTRACT 
The purpose of this project is to increase the adherence of clinic providers to the American 
Academy of Sleep Medicine’s Clinical Guidelines for the Evaluation, Management, and Long-
term Care of Obstructive Sleep Apnea in Adults. OSA is a chronic condition that effects from 
2% to 10% of the U.S. adult population. Implications of undiagnosed OSA include excessive 
daytime sleepiness, fatigue, irritability, difficulty controlling chronic diseases including diabetes 
and hypertension, heart arrhythmias, gastroesophageal reflux disease, mood disorders, attention 
deficit disorder, and an increased potential for dementia if left untreated. A protocol was created 
to align providers with the clinical guidelines. Provider responsibilities included screening all 
patients 18 and over for OSA, referring patients with a positive screen for a sleep study, 
prescribing CPAP when indicated, and providing short-term follow-up. At project completion 
293/405 patients (72%) ages 18 and over had been screened, 58 (20%) had positive screens, 53 
(91%) with a positive screen were referred for sleep study, 19 (35%) completed the sleep study, 
19 (100%) were diagnosed with OSA and prescribed CPAP, and 18 (95%) were scheduled for 
short-term follow-up. There were no significant differences noted between age distribution and 
the receipt of a positive diagnosis of OSA, F (3,504) = .066, p = .679. During implementation 19 
(7%) patients were identified and treated for OSA. The relationship between using a screening 
tool to assess risk of OSA and receipt a positive diagnosis of OSA was significant, χ2 (1, 505) = 
5.982, p < .05. Only 19 out of 53 patients referred for sleep study completed a sleep study 
indicating a need for continued work on intervention models that will facilitate patient 
completion of diagnostic testing with subsequent referral for treatment.  
Keywords: obstructive sleep apnea, OSA, sleeping disorder, CPAP, guideline adherence 
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Obstructive Sleep Apnea (OSA) is a common condition that affects a significant portion 
of the U.S. population. Although most people have heard of OSA, multiple misconceptions exist 
among both patients and providers. These are some common misconceptions: all patients with 
OSA snore, only people who are overweight can have OSA, the only method for diagnosis is 
overnight polysomnography, OSA has only short-term side effects (daytime sleepiness, fatigue), 
if you have insomnia you cannot have OSA, sleep studies are not well-covered by insurance, all 
continuous positive airway pressure (CPAP) machines are loud and blow constant air, and only 
sleep specialists can diagnose and manage OSA.  Providers and patients need to be educated as 
to the implications of undiagnosed OSA, which include excessive daytime sleepiness, fatigue, 
irritability, difficulty controlling chronic diseases including diabetes and hypertension, heart 
arrhythmias, gastroesophageal reflux disease (GERD), mood disorders, attention deficit disorder, 
and an increased potential for dementia if left untreated.  
 Obstructive sleep apnea increases the risk for vehicular collisions, poor work 
performance, workplace accidents, and incidents of aggression, that affect more than just the 
individual afflicted with OSA. By studying the aspects of OSA and utilizing that knowledge to 
identify, treat, and manage this patient population, primary care providers (PCPs) have the 
potential to make a difference in the lives of these patients, their families, and the community.  
Statement of the Problem 
Obstructive sleep apnea is a complex condition that is caused by a variety of different 
mechanisms. It is currently estimated that from 2% to 10% of the U.S. adult population has OSA 
(Epstein et al., 2009; Grover et al., 2011). After the age of 65 the incidence of OSA increases 
from 12% to 25% (Mold et al., 2011). There are many adults and children in the United States 
that have unrecognized OSA. Presently there is a lack of screening, diagnosis, treatment, and 
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management of OSA in primary care (Drager et al., 2011; Epstein et al., 2009; Grover et al., 
2011).  
Background and Significance 
Untreated OSA has a hazardous effect on the individuals that are afflicted.  Short-term 
effects include fatigue, irritability, excessive daytime sleepiness, anxiety, depression, snoring, 
insomnia, increased blood pressure and heart rate, and an inability to properly control pain 
(Epstein et al., 2009; Ronksley, Hemmelgarn, & Tsai, 2011). OSA has been linked to difficulty 
controlling diabetes and other metabolic disorders (Storgaard, Mortensen, Almadal, Laub, & 
Tarnow, 2014). Storgaard et al. (2014) discovered that approximately one third of the 200 
diabetic patients studied had OSA. Patients with OSA are two to three times more likely to be 
involved in a car accident (Strohl et al., 2013). Untreated moderate to severe OSA is estimated to 
cost society around 3.4 billion dollars a year in indirect medical costs; this estimate does not take 
into account money in lost wages and other non-medical side effects (Ronksley et al., 2011). 
There appears to be a bi-directional link between GERD and sleep disorders. Evidence 
suggests that GERD can cause shortened periods of sleep, insomnia, sleep awakenings, poor 
quality of sleep, and early morning awakenings (Fujiwara, Arakawa, & Fass, 2012; Jung, 
Choung, & Talley, 2010). Evidence also suggests that loss of sleep itself, due to an underlying 
sleep disorder, can cause an increase in acid production perfusion leading to many of the 
symptoms associated with GERD (Fujiwara et al., 2012; Jung et al., 2010). Long-term untreated 
sleep apnea has been linked to heart arrhythmias, increased risk for congestive heart failure, heart 
attack, and stroke (Epstein et al., 2009; Ronksley et al., 2011). Scientists believe that a lifetime of 
untreated OSA may in fact lead to certain types of dementia (Elwood et al., 2011). One of the 
best ways to prevent dementia is to determine if the patient has OSA and, if so, treat it (Fotuhi, 
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2009). The failure to diagnose and treat OSA is in part due to a lack of screening by primary care 
providers (Drager et al., 2011; Epstein et al., 2009; Grover et al., 2011; Storgaard et al., 2014). 
According to the American Academy of Sleep Medicine (AASM) guideline for OSA, 
routine health evaluations should contain OSA screening questions, and if there is suspicion of 
OSA, then further testing should be completed (Epstein et al., 2009). According to the AASM 
guidelines, “Clinically, OSA is defined by the occurrence of daytime sleepiness, loud snoring, 
witnessed breathing interruptions, or awakenings due to gasping or choking in the presence of at 
least 5 obstructive respiratory events (apneas, hypopneas, or respiratory effort related arousals) 
per hour of sleep.” (Epstein et al., 2009, p. 263) An apnea episode is a pause in breathing during 
sleep (usually greater than 10 seconds in adults) and hypopnea is a substantially reduced or 
ineffective breath (Eckert & Malhotra, 2008). An OSA diagnosis is based on an individual’s 
apnea/hypopnea index (AHI). The AHI is obtained by dividing the number of respiratory events 
by the number of hours of testing (Epstein et al., 2009). If the AHI is five or greater a diagnosis 
of OSA is made. Degree of OSA is classified into none (AHI <5), mild (AHI of 5-15), moderate 
(AHI of 16-30), or severe (AHI >30) (Epstein et al., 2009).  
The main mechanisms of OSA appear to be upper airway anatomy, upper airway dilator 
muscle activity, arousal from sleep, ventilator control stability, lung volume, genetics, and 
several physiological factors (Casale et al., 2009; Dempsey, Veasey, Morgan, & O'Donnell, 
2010; Eckert & Malhotra, 2008). There appears to be a strong genetic link to OSA with 35-40% 
of the risk factors being based on genetic components (Casale et al., 2009). Most respiratory 
events cause cortical arousal with the length and degree of arousal appearing to be directly 
related to the severity of the apnea/hypopnea event (Dempsey et al., 2010; Eckert & Malhotra, 
2008). When the airway is obstructed, the oxygen levels drop until the brain is aroused enough to 
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cause the individual to breathe. This leads to cycles of sleep, deoxygenation, and arousal making 
true restorative sleep difficult (Eckert & Malhotra, 2008). In severe cases, patients can have 
respiratory events 100 or more times each hour (Eckert & Malhotra, 2008). 
The AASM guidelines recommend screening for OSA in primary care to determine 
which patients should be referred for diagnostic testing (Epstein et al., 2009). The guidelines 
stress the importance of a thorough history and physical to screen for sleep-related disorders 
including complications such as excessive daytime sleepiness, as measured by the Epworth 
Sleepiness Scale (ESS), snoring, and other comorbid conditions (Epstein et al., 2009).  
There are two methods for diagnosis of OSA endorsed by the AASM. These consist of 
nocturnal polysomnography or an at-home sleep study (Epstein et al., 2009). Nocturnal 
polysomnography requiring a minimum of electroencephalogram, electrooculogram, chin 
electromyogram, airflow, oxygen saturation, respiratory effort, and electrocardiogram or heart 
rate, is conducted in a sleep laboratory under supervision of a trained specialist (Epstein et al., 
2009). An at-home sleep study requires a minimum airflow record, respiratory effort, and blood 
oxygenation (Epstein et al., 2009). After sleeping with the device for several nights the at-home 
monitor is returned, the recording is analyzed, and then a computer generated report is sent to the 
clinic that includes the AHI, oxygenation statistics, and snoring characteristics per night of study. 
Regardless of which method is used, the number of respiratory events is divided by the hours of 
study and if the resultant AHI is five or greater a diagnosis of OSA is made (Epstein et al., 2009; 
Rosen et al., 2012).  
Obstructive sleep apnea (OSA) is rarely curable based on the underlying pathophysiology 
involved. Most treatment methods aim at life-long symptom management. There are three main 
categories for treatment of OSA which include medical, behavioral, and surgical 
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interventions/treatments (Epstein et al., 2009; National Heart Lung and Blood Institute [NHLBI], 
2012). There are two main medical treatment methods endorsed by the AASM. One method is 
the use of an oral appliance that modifies the position of the jaw to help maintain an open airway 
(Epstein et al., 2009; Lam et al., 2007; Phillips et al., 2013). The other medical treatment method 
is positive airway pressure (PAP) administered via a nasal mask or full face mask which is 
connected to a CPAP machine (Epstein et al., 2009; Lam et al., 2007; NHLBI, 2012; Strohl et al., 
2013). Behavioral treatment options include weight loss, exercise, and good sleep hygiene which 
consists of regular bedtimes, avoiding alcohol and caffeine, and only using the bed for sleeping 
(Epstein et al., 2009; NHLBI, 2012). Surgical treatment methods are aimed at correcting the 
underlying pathophysiology. Identifying and treating patients that have OSA may lead to a 
significant reduction in signs and symptoms associated with OSA and improve the future health 
of these individuals. 
Assessment 
A family practice clinic in the south central United States was the site for implementation 
of an evidence-based project related to aligning the practice with the AASM guidelines for the 
screening, diagnosis, treatment, and management of patients with OSA. The staff involved in this 
project included the providers (1.0 physician, 1.0 family nurse practitioner [FNP], and 0.2 
women’s health nurse practitioner), front and back desk receptionists, three medical assistants 
(MA), the medical records personnel, and the office manager/referral coordinator. 
The clinic has an estimated 6,000 active patients and sees an average of 250 patients a 
week ages 13 and over.  Approximately 2% of patients are 13-17, 13% are 18-24, 25% are 25-
44, 40% are 45-64, and 20% are 65 or older. The male/female ratio averages 50:50. The patients’ 
ethnic/racial background is 30% Hispanic White, 30% Non-Hispanic White, 30% Non-Hispanic 
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Black, and 10% of patients classified as other. The majority of patients speak either English or 
Spanish and the majority of the staff is bilingual English/Spanish.  
A June 2016 microsystem assessment indicated that the clinic had a high percentage of 
patients at increased risk for OSA based on their presenting diagnoses of ADD 4 (4%), 
hypertension 54 (54%), diabetes mellitus 25 (25%), insomnia 16 (16%), heart arrhythmia 1 (1%), 
mood disorders 29 (29%), chronic pain 36 (36%), obesity 11 (11%), headache 2 (2%), GERD 22 
(22%), and dementia 1 (1%).  The AASM clinical guidelines call for screening, referral for 
diagnostic study when indicated, treatment, and management of patients at high risk for OSA. 
The clinic had no protocol in place to address the risk for OSA in the clinic’s patients. 
Organization’s Readiness for Change  
Upon review of the AASM guidelines and the results of the June 2016 microsystem 
assessment with the key stakeholders it was determined that the clinic was not aligned with the 
AASM clinical guidelines. Prior to review of the guidelines the clinic providers had been 
unaware of the severity and potential complications associated with OSA. Following review of 
the guidelines it was determined that a protocol needed to be established to align the practice 
with the AASM guidelines. All providers and staff expressed a willingness to participate in a 
project to implement the evidence-based AASM guidelines for OSA in the clinic as a method of 
improving the quality of care. 
Working with the lead physician and office manager a protocol was established to 
address OSA. Each provider was interviewed to determine their current knowledge of OSA.  
Although the providers varied in their understanding of OSA, it was determined that all 
providers needed more information in order to properly address OSA with patients.  
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Twenty patients were interviewed prior to project implementation to determine current 
patient knowledge of OSA and potential barriers to participation. The ESS was presented and the 
process for diagnosis and treatment explained. Nineteen out of the twenty patients interviewed 
had no knowledge of OSA. The only patient, with a basic understanding of OSA, had a previous 
diagnosis of OSA, and was currently receiving treatment with CPAP. All patients interviewed 
expressed a willingness to participate in the OSA screening. No barriers to patient participation 
in OSA screening were noted. 
Project Identification 
Purpose and Objectives 
The purpose of this evidence-based project was to increase adherence of the clinic’s 
providers to the AASM Clinical Guidelines for the Evaluation, Management, and Long-term 
Care of Obstructive Sleep Apnea in Adults (2009), thereby improving the quality of care 
provided. The AASM guidelines call for screening, referral for diagnostic study when indicated, 
treatment, and management of patients at risk for OSA in primary care.    
The objectives of this evidence-based project to improve quality of care are to: 
1. Increase patient screening for obstructive sleep apnea from the pre-intervention rate of 
0% to 90% by the completion of the fourth week of project implementation.  
2. Increase the percentage of patients who require follow-up that receive a referral for a 
sleep study from less than 3% to 90%. 
3. Increase the number of patients with a positive diagnosis of OSA who are offered a 
prescription for CPAP from pre-intervention rate of 0% to 90% by the 10th week 
following project initiation. 
IMPROVING ADHERENCE OF PROVIDERS TO AASM GUIDELINES    15 
 
4. Increase the short-term follow-up of the clinic’s patients who initiated CPAP treatment 
from 0% to 90% according to recommendations from the AASM clinical guidelines that 
suggest patient’s success with CPAP usage is generally determined within the first few 
weeks following CPAP initiation, and routine short-term follow-up has been shown to 
increase CPAP compliance. 
Anticipated Outcomes  
By meeting these objectives, there will be an increase in patients identified; providers 
will make appropriate referrals for sleep studies; there will be a decrease in signs and symptoms 
associated with OSA such as excessive daytime sleepiness, insomnia, and fatigue; there will also 
be a reduction in the severity of comorbidities, (hypertension, diabetes mellitus, mood disorders, 
GERD, headaches, and pain) among patients receiving treatment. The clinic will align with 
Healthy People 2020 goals for OSA and be in compliance with the AASM’s guidelines. 
Summary and Strength of the Evidence 
Multiple studies were appraised that demonstrated the methods by which providers can 
address the aspects of OSA through screening, referral for diagnosis, proper treatment, and 
management of patients at high risk for OSA.  This information was synthesized and the 
resultant information was used to create the OSA protocol for the clinic. 
Among four studies there was a consensus that there is a lack of screening among 
primary care providers for OSA (Brostrom et al., 2012; Grover et al., 2011; Mold et al., 2011; 
Wall, Smith, & Hubbard, 2012).  There are multiple comorbidities such as refractory 
hypertension, mood disorders, obesity, GERD, diabetes, fatigue, and other uncontrolled disorders 
that have been shown to put a patient at high risk for OSA (Alam, Chengappa, & Ghinassi, 2012; 
Drager et al., 2010; Fujiwara et al., 2012; Jung et al., 2010; Kleisiaris et al., 2016 ;Wall et al., 
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2012).  Brostrom et al. (2012) conducted a study of primary care patients that had a diagnosis of 
hypertension. Polysomnography was performed on the study’s 394 patients with 234 (59%) of 
the patients diagnosed with OSA (Brostrom et al., 2012). Four studies noted as the number of 
comorbidities a patient has associated with OSA increases, the patients risk for OSA increases 
(Alam et al., 2012; Drager et al., 2010; Kleisiaris et al., 2016; Wall et al., 2012).   
Often times the primary care practice is the first place that patients at risk for OSA are 
seen and according to the literature patients in the primary care setting are not being assessed for 
OSA even though they are at increased risk (Alam et al., 2012; Brostrom et al., 2012; Drager et 
al., 2010; Kleisiaris et al., 2016; Mold et al., 2011; Wall et al., 2012). Mold et al. (2011) in a 
study of 725 patients with a positive diagnosis of OSA noted that even though there was a 
significant portion of patients with a positive diagnosis of OSA, few providers could name a 
single patient that had symptoms associated with OSA, or a positive diagnosis of OSA. Lack of 
provider screening and knowledge of OSA has been cited by studies one of the biggest hurdles to 
proper OSA diagnosis and management (Alam et al., 2012;  Drager et al., 2010; Kleisiaris et al., 
2016; Mold et al., 2011; Wall et al., 2012 ).  
After a patient has a positive screening test the next step in the process is referral for a 
sleep study. The two main methods for sleep study endorsed by the AASM include overnight 
polysomnography completed at a sleep center or an at home sleep study (Epstein et al., 2009).  
No matter which method of sleep study is chosen, diagnosis of OSA is made based on the AHI 
(number of respiratory events in an hour) with an AHI of 5 or greater confirming the presence of 
OSA.  
After the diagnosis of OSA is confirmed the patient can either be managed by their 
primary care provider (PCP) or a sleep specialist. The PCP’s lack of knowledge about OSA can 
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serve as a barrier that may be negated by instruction on OSA diagnosis, treatment, and 
management (Chai-Coetzer et al., 2013). In the study by Chai-Coetzer et al. (2013) it was 
determined that the PCP could manage OSA patients just as well as specialists, while 
maintaining a higher level of patient satisfaction. Patients are more likely to follow the advice of 
their PCP because they have already established a relationship with their provider allowing PCPs 
to play an integral role in the screening, diagnosis, and treatment of OSA and other comorbidities 
associated with OSA (Alam et al., 2012; Chai-Coetzer et al., 2013; Drager et al., 2010; Kleisiaris 
et al., 2016; Mold et al., 2011; Wall et al., 2012).   
Once a patient receives the diagnosis of OSA, it becomes the responsibility of the PCP to 
explain the implications of the disease and the different methods for treatment and management 
(Epstein et al., 2009). The two methods of OSA medical management endorsed by the AASM 
are CPAP and the use of an oral appliance (Epstein et al., 2009; Lam et al., 2007; Phillips et al., 
2013). Of the two methods, CPAP was proven to be the most effective form of treatment for 
OSA having the largest reduction in OSA signs and symptoms (Lam et al., 2007; McMillan et 
al., 2015; Phillips et al., 2013). It was noted however that oral appliances had a slightly better 
compliance rate (Phillips et al., 2013). McMillan et al. (2015) reported that sleep hygiene had a 
positive effect on the symptoms associated with OSA, but the impact was greater when 
combined with CPAP. Treatment with CPAP lowered the degree of excessive daytime sleepiness 
as evidenced by a reduction in scores on the ESS after treatment with CPAP in four studies 
(Chai-Coetzer et al., 2013; Lam et al., 2007; McMillan et al., 2015; Phillips et al., 2013).  Adults 
65 and older also experienced significant improvement in OSA signs and symptoms by using 
CPAP (McMillan et al., 2015). Alam et al. (2012) conducted a study of patients with a diagnosis 
of a mental health disorder being treated in primary care to determine the willingness of this 
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population to participate in diagnostic study and treatment for OSA when applicable. When 
interviewed the majority of patients with mental health disorders expressed a willingness to 
undergo sleep study and if found positive for OSA be treated with CPAP (Alam et al., 2012). 
It is not enough to prescribe CPAP for patients who test positive.  Between 29-83% of 
patients are non-adherent to CPAP usage (Weaver, 2014). The more severe OSA a patient has, 
the better the compliance with CPAP (Pruitt, 2008). Several studies have shown that the risk for 
non-compliance is usually determined within the first few weeks of initiation of therapy (Pruitt, 
2008; Weaver, 2014). There are several interventions that can be done to address non-
compliance. First, it is important to have follow-up within the first few weeks of initiation of 
CPAP to address any questions or concerns (Epstein et al., 2009; Pruitt, 2008). It is also 
suggested that because OSA is a chronic condition, patients with this diagnosis should be 
evaluated again within three to six months, and then on a yearly basis to continue to monitor 
disease progression, CPAP usage, and address concerns that may arise (Epstein et al., 2009; 
Pruitt, 2008; Weaver, 2014). Even though there are various studies that show the multiple 
aspects of OSA, there is not any one study or improvement project that provides an effective 
protocol for screening, diagnosis, treatment, and management of OSA.  
Methods 
Project Intervention  
A pre-intervention chart audit was performed on 100 patients seen in the clinic during the 
week of 5/9/2016-5/13/2016. The data, analyzed in IBM® SPSS® version 23, demonstrated that 
91 (91%) of the patients had diagnoses placing them at high risk for OSA, 0 (0%) of the patients 
had been screened for OSA, and only 4 (4%) of these patients had been referred in the past for a 
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sleep study.  There was no evidence that follow-up appointments to monitor OSA progression 
and CPAP usage had been conducted in the charts of patients with a positive diagnosis OSA. 
Prior to implementation, one-on-one interactive education was conducted with each 
provider on the aspects of OSA including background, significance, screening with the ESS, 
referral for sleep study, interpretation of sleep study results, treatment, and management of OSA 
(see Appendix  A). Each provider was given a copy of the clinic’s Provider OSA Handbook to 
use as a resource during implementation. The handbook included the ESS in English (see 
Appendix B) and Spanish, official office protocol (see Appendix C), patient teaching materials 
obtained with permission from the AASM, a checklist for follow-up appointments, sample CPAP 
prescription (see Appendix E), and a copy of the AASM guidelines. Prior to initiation of the new 
OSA protocol interactive education was conducted with members of the staff discussing the 
different roles and responsibilities during implementation of the clinic’s OSA protocol. 
 Starting on day one of implementation each patient 18 and older entering the clinic was 
given a copy of the ESS to fill out in English or Spanish based on the language of their choice by 
the front receptionist. After completion, the patient gave the form to the medical assistant (MA). 
The MA totaled the ESS and placed the total score at the top of the form.  The ESS was then 
given to the provider along with the patient’s paperwork prior to seeing the patient.  
If the score was 10 or more the provider explained the risk for OSA to the patient and 
offered a referral for a sleep study. If the patient accepted the referral, the provider wrote a sleep 
study prescription. The front desk then made an appointment with a representative for a home 
sleep study. 
Once the study was completed the patient returned the sleep study machine and 
scheduled an appointment to discuss the sleep study results. One week before the return visit, the 
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records department checked to see if the sleep study results were obtained. If no results were 
available the sleep study representative was contacted. If results were still unavailable the day 
before the visit the patient was notified by the MA and offered a chance to reschedule at their 
convenience. Upon return for the follow-up appointment, the provider reviewed the sleep study 
results with the patient. 
Patients with a positive diagnosis were educated on treatment and management of OSA. 
All patients that tested positive for OSA were prescribed CPAP. If the patient agreed to CPAP 
initiation, a task was sent to the referral coordinator along with the prescription, for an automatic 
titrating CPAP machine and supplies. Upon referral for CPAP the patient was scheduled for a 
follow-up appointment within two to six weeks to discuss CPAP initiation and OSA progression.  
The referral coordinator then sent a referral to a Durable Medical Equipment (DME) 
vendor for the auto-titrating CPAP machine and supplies. The patient was called by a MA two 
weeks after referral was sent to the DME to determine if the CPAP machine and supplies were 
received. When the patient returned for the follow-up appointment the provider assessed CPAP 
usage and OSA status by utilizing the checklist to help guide the follow-up visit. The patient was 
given a copy of the ESS to fill out at all follow-up visits to determine impact of CPAP treatment 
on OSA progression. After the visit was concluded the patient was scheduled for a follow-up 
visit 3-6 months later to discuss CPAP usage and OSA progression.  
Following implementation of the protocol, every patient 18 and older entering the office 
for provider visit during the first four weeks of project implementation was included in post-
intervention data collection and analysis. There were 407 patients seen at the clinic during these 
four weeks. All patients were tracked through each step of the protocol from the first week of 
implementation through the tenth week following project initiation. 
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Prior to initiation of the project, the proposed plan was submitted to the University of the 
Incarnate Word Institutional Review Board (IRB) for approval.  The project was approved by 
exempt review as it was determined to be less than minimal risk indicating no known physical, 
emotional, psychological, or economic risk for the individual participating. The IRB approval 
number is 16-05-013. 
Organization Barriers and Facilitators 
The organization experienced multiple challenges with the implementation of the new 
protocol. Barriers included failure to screen patients, fluctuation with provider coverage, and 
fluctuation with MA staffing levels, patient misconceptions, and receiving CPAP equipment and 
supplies in a timely manner. Staff had difficulty remembering to give patients the ESS. During 
the first week of project implementation the screening rate was 65.8%. Adjustments were made 
to the screening process based on data obtained during the first two weeks of implementation and 
input from staff and providers. By the fourth week of project implementation the clinic screening 
rate had increased to 80.5%. 
Fluctuation in provider coverage occurred. The Provider Handbook for OSA served as a 
valuable tool to keep all providers informed about the aspects of OSA and the clinic protocol.   
Fluctuation in MA staffing levels occurred. After an initial period of adjustment, the MA’s 
increased compliance to the OSA protocol. 
Patient barriers to OSA protocol implementation were mainly due to misconceptions and 
lack of CPAP machines and supplies. Misconceptions were related to the causes and symptoms 
of OSA, types of methods for diagnosis of OSA, cost of sleep studies and treatment methods, 
and outdated information on CPAP machines and supplies. Patient education provided by the 
clinician regarding signs, symptoms, co-morbidities, diagnosis, treatment, and management of 
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OSA reduced the patient’s reluctance to consider treatment. Because patients had difficulty 
receiving CPAP machines and supplies in a timely manner the referral coordinator followed up 
with the DME to ensure equipment and supplies were delivered to patients. If necessary, follow-
up appointments were rescheduled to accommodate for the lack of CPAP equipment and 
supplies. 
Facilitators to the new protocol included staff familiarity with stages of the OSA 
protocol, an affiliation with a home sleep study vendor and DME companies, increased revenue 
from enactment of the OSA protocol, and patient willingness to participate in project. The clinic 
staff was familiar with the process of scheduling a patient for a sleep study and follow-up 
appointment for results. An affiliation with a home sleep study vendor made it easier to refer 
patients for a study. The referral coordinator already had affiliations with two DME vendors that 
supply CPAP equipment and supplies.  
The clinic received increased revenue based on increased visits and billable procedures 
involved with operationalization of the OSA protocol. Utilization of an official protocol for OSA 
increases insurance reimbursement, decreases the chance for denial of benefits, which may lead 
to an increase in the number of patients with a high risk of OSA that can receive diagnostic 
testing, and treatment of OSA if found positive. Most patients in the clinic expressed willingness 
to participate in the OSA project. There were 294 patients approached for screening using the 
ESS and 293 (99.7%) agreed to be screened. The clinic has the paperwork and information 
necessary to help patients that are unable to afford the CPAP machine and supplies to apply for 
the CPAP Assistance Program, and if eligible they will receive the machine and equipment for a 
nominal fee (American Sleep Apnea Association, 2015).  
Results 
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The total number of eligible patients that entered the practice during the four weeks of 
implementation was 405. Of these eligible patients 293 (72%) were screened using the ESS. The 
overall clinic rate fluctuated throughout the course of project implementation. The percentage of 
patients screened each week increased by provider throughout project implementation with some 
fluctuation. 
Table 1 
Weekly Screening Rate  
Week       Provider 1 Provider 2 Provider 3 Total Clinic  
Week 1      61%                  92%                65.80% 
Week 2      100%     67%                  93%     76.50% 
Week 3        89%     44%                100%     57.00% 
Week 4      100%     73%                 86%                 71.00% 
 
In the four weeks of implementation, 58 (20%) patients screened had positive ESS screen 
for OSA. Of the 58 patients with a positive OSA screen 53 (91%) were referred for a sleep study. 
The information was further broken down by provider to determine each provider’s adherence. 
The weekly percentage of patients with a positive screen that were referred for a sleep study 
increased steadily for each provider with some variability. The clinic rate increased week to 
week with some fluctuation (table 2).  
During the course of the project 19 patients completed a sleep study with 19 (100%) 
receiving a positive diagnosis of OSA. Of the 19 patients receiving a diagnosis for OSA, 19 
(100%) were initiated on CPAP.  Based on the data collected throughout the ten weeks of project 
implementation, 18 (95%) of patients who initiated CPAP were scheduled for a follow-up 
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appointment but at conclusion of the project only 13 (72%) of those appointments had been 
completed. 
Table 2 
Weekly Referral Rate 
Week    Provider 1 Provider 2 Provider 3 Total Clinic 
Week 1        25%    100%       40% 
Week 2    100%      75%    100%       88% 
Week 3    100%        0%    100%       60% 
Week 4    100%    100%    100%     100% 
 
Of the 19 patients diagnosed with OSA 7 (37%) had diabetes, 12 (63%) were obese, 8 
(42%) had insomnia, and 10 (53%) had hypertension. Of the 274 patients that were screened and 
not diagnosed with OSA 80 (29%) had diabetes, 126 (46%) were obese, 60 (22%) had insomnia, 
and 144 (53%) had hypertension.  
Age distribution was comparable between both the screened and non-screened population 
with the largest population falling within the 25-44 year olds and the smallest population in the 
18-24 year olds. 
A one way ANOVA was run to determine if there was statistical significance in age 
distribution and receiving a positive diagnosis of OSA. There were no significant differences 
noted between age distribution and the receipt of a positive diagnosis of OSA, F (3,504) = .066, 
p = .679 (table 3). 
A chi-square test of independence was performed, including both the pre-intervention and 
post-intervention data that was collected, to examine the relationship between using a screening 
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tool to assess risk of OSA and receipt of a positive diagnosis of OSA. The relationship between 
these variables was significant, χ2 (1, 505) = 5.982, p < .05 (table 4). 
Figure 1 
Diagnoses present among screened patients associated with OSA 
 
Figure 2 
Age distribution of patients  
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Table 3 
ANOVA: Age Distribution Diagnosis of OSA  
                    Sum of Squares df     Mean Square      F        Sig. 
Between Groups             .066              3    .022         .505       .679 
Within Groups     21.886            501    .044   
Total                         21.952            504    
 
Table 4 
Chi-square: Relationship Between Screening for OSA and Diagnosis 
                                       Value    df  Asymptotic      Exact Sig.       Exact Sig. 
                                                                        Significance           (2-sided)      (1-sided)                                  
                                                                          (2-sided)              
Pearson Chi-Square           5.982a               1                         .014 
Continuity Correction        4.971           1                 .026 
Likelihood Ratio                6.649           1                 .010  
Fisher's Exact Test                                                                               .016              .010 
Linear-by-Linear                5.970    1           .015 
Association 
N of Valid Cases                                505 
Note. a. 0 cells (0.0%) have expected count less than 5. The minimum expected count is 9.66. 
There were 23 (10%) patients that did not have a positive screen that could name 
at least one person they knew that fit the criteria of high risk for OSA. Many of these patients 
stated that they would recommend a sleep study to these individuals. There were approximately 
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15 (5%) of patients screened that had previously received a diagnosis for OSA that were not 
presently being treated. According to the providers, the most frequently stated reason given by 
the patients for lack of treatment was patient misconceptions of CPAP treatment. After 
explanation of the at-home sleep study and the newer CPAP machines, most of these patients 
agreed to a repeat sleep study and use of CPAP if they were still found to have a positive 
diagnosis of OSA. The majority of patients screened expressed interest in the information 
obtained on OSA and many expressed gratitude for being included in the screening process. 
 Discussion  
The ESS was not consistently given to all patients that entered the office during the first 
four weeks of project initiation. Without completed ESS forms the provider was not prompted to 
proceed in the OSA protocol. The lack of receipt of the ESS form impacted the overall screening 
adherence rate leading to missed opportunities to identify patients that may benefit from further 
testing. Provider adherence in both screening and referral for sleep study improved over the 
course of the project enabling more patients to be identified and referred for testing.  
Many patients had misconceptions about aspects of OSA. Common misconceptions 
stated by the patients included:  
 “I thought the only way a person can find out if they have sleep apnea is by going to a 
sleep center to have a sleep study done.”  
 “I thought only people who snore can have sleep apnea.” 
 “You have to be overweight to have sleep apnea, right?” 
 “I don’t want to use CPAP because I heard that the machines are loud.”  
 “Aren’t CPAP machines loud and bulky?” 
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 “My grandma used to have CPAP and it sounded and looked like she was sleeping in a 
wind tunnel because there was so much air pressure.” 
 “Isn’t it hard to get insurance to pay for a sleep study or a CPAP machine?” 
 “Sleep apnea can only be diagnosed and treated by a sleep specialist.” 
 “I already know I have sleep apnea but I don’t want to use CPAP because I heard the 
machines are loud, large, and blow air all the time making it hard to breathe!”  
 “I know I have sleep apnea but I refuse to go to one of those creepy overnight sleep 
studies where people stare at you while you sleep and they put a bunch of wires on you!” 
After patient education, approximately 48 (91%) of patients with a positive screen for 
OSA, referred for a sleep study, expressed a willingness to participate in an at home study, and if 
diagnosed with OSA, consider treatment by CPAP. 
Patients that use CPAP have been noted to have an improvement in excessive daytime 
sleepiness by as much as 10-15 points (Chai-Coetzer et al., 2013). There was a noticeable 
improvement in the signs and symptoms associated with OSA in clinic patients that received 
treatment. Patients placed on CPAP were re-screened with the ESS upon their follow-up 
appointment. Every patient that was placed on CPAP had reduction in their ESS score to a mean 
of 5 from their pre-intervention mean score of 16. One patient diagnosed with severe OSA (AHI: 
76.8), had no known comorbidities associated with OSA, and upon treatment with CPAP, the 
patient had a reduction in ESS score from 16 pre-intervention to 6. Not all patients that have 
OSA have multiple comorbidities associated with OSA. The AASM guidelines for OSA call for 
routine screening for OSA by use of a tool, such as the ESS, in primary care to aid in the 
identification of patients at risk for OSA that might otherwise be missed (Epstein et al., 2009). 
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The rate of sleep apnea among adults in the U.S. is estimated to range between 2-10% of 
the population (Epstein et al., 2009; Grover et al., 2011). Of the 293 patients screened in the 
practice, 19 (7%) received a positive diagnosis for OSA which falls within the national average. 
Of the 53 patients referred for sleep study 19 (35%) completed the sleep studies indicating a need 
for continued work on intervention models that will facilitate patient completion of diagnostic 
testing with subsequent referral for treatment Of the 19 patients that followed through with the 
sleep study, 19 (100%) received a positive screen. Analysis of the chi-square demonstrated that 
patients that are screened for OSA by use of a screening tool are more likely to receive a positive 
diagnosis of OSA. 
Obesity defined as a BMI >30 was present in 30% of patients with mild sleep apnea and 
60% of patients with severe sleep apnea in a study by Brostrom et al. (2012). In the project 
patient population obesity was present in 50% of patients with mild sleep apnea and 60% of 
patients with severe sleep apnea. In the project patient population 10 (53%) of patients with a 
positive diagnosis of OSA had hypertension and 7 (37%) of patients with a positive diagnosis of 
OSA had diabetes. Four studies noted as the number of comorbidities a patient has associated 
with OSA increases, the patients risk for OSA increases (Alam et al., 2012; Drager et al., 2010; 
Kleisiaris et al., 2016; Wall et al., 2012). Of the 19 patients that were diagnosed with OSA, 14 
(74%) had three or more comorbidities that are associated with OSA supporting the claim that 
the number of comorbidities has an effect on the risk for OSA. 
In the clinic, it was discovered that 58 (20%) of patients screened were at high risk for 
OSA. Of the 293 patients screened in the clinic, 20 (34%) of those with a positive screen had a 
documented sleep related complaint compared to Mold et al. (2011) where less than one third of 
their patients with a positive screen had a previous documented sleep related complaint. 
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The protocol as it stands has been shown to be a viable method for identifying and 
treating patients at high risk for OSA. Having a provider handbook was a practical method for 
keeping all providers informed of OSA facts, and provided the tools necessary for protocol 
completion.  One of the most important aspects of the OSA protocol is that it is transferable to 
other practices. This project is replicable and the protocol can be taken by any primary care 
practice and adjusted as needed to fit the individual office and staff.   
Limitations 
 There were several changes in providers and staff throughout the course of project 
development and implementation that may have affected the overall screening and referral rates. 
The addition of new providers and staff required education and the opportunity to incorporate the 
process into their routine. There were only 293 out of 407 patients that entered the clinic during 
the first four weeks of project implementation that were screened using the ESS. The lack of 
screening of the other 114 patients affected the total number of patients screened potentially 
decreasing the number of patients identified and treated for OSA.  Out of the 53 patients with a 
positive screen that were referred for a sleep study, only 19 completed a sleep study. Had the 
other 34 patients completed a sleep study there may have been more patients with a positive 
diagnosis of OSA. 
Recommendations 
 There were a significant number of clinic patients that met the criteria of high risk for 
OSA based on the signs, symptoms, and comorbidities associated with OSA. Since OSA is 
classified as a chronic condition, the AASM recommends that routine screening be performed in 
primary care practices and patients receiving a positive diagnosis of OSA be followed up at least 
yearly. Only 293 (72%) of patients were screened for OSA and19 (36%) of patients referred for 
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sleep studies completed the sleep studies indicating a need for continued work on screening 
methods that will increase provider and staff compliance, and intervention models that will 
facilitate patient completion of diagnostic testing with subsequent referral for treatment.  
Implications for Practice  
There were 0/212 (0%) patients diagnosed with OSA in the non-screened patient 
population. Of the patients screened during project implementation there were 19/293 (7%) 
diagnosed with OSA. The results of the QI project demonstrated that screening patients for OSA 
using the ESS can help in the identification and treatment of patients with OSA. In the clinic 58 
patients were identified as high risk for OSA out of 293 patients screened indicating that 58 
(20%) screened had a positive screen for OSA. From this knowledge one can infer that other 
primary care practices and their patients could benefit by putting a protocol in place to address 
the risk for OSA in primary care.  
Even though this project was implemented at a primary care office, a similar protocol 
could be implemented at other specialty practices that care for patients with one or more of the 
major comorbidities associated with OSA. By use of a modified version of the protocol, more 
patients potentially at high risk for OSA could be identified increasing the identification, 
treatment, and management of patients that were previously underdiagnosed. 
The ESS is available free of charge for providers making it a simple and cost-effective 
method to screen patients for OSA. The ESS has been translated and validated in multiple 
languages around the world making it an optimal tool to identify patients at increased risk for 
OSA. The protocol is applicable not just in the United States, but could be implemented in 
provider offices across the globe with slight modifications based on location and practice. 
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For a protocol to be successful there must be a method of oversight to ensure proper 
implementation, including changes as necessary, to increase adherence by providers and staff. 
The Advanced Practice Registered Nurse (APRN) is in a key position to offer this oversight. 
Implementing guidelines to screen, diagnose, treat, and manage patients at high risk for OSA has 
the potential to have a significant impact on the patient population.  The APRN is capable of 
screening, referring for diagnostic testing, giving a comprehensive explanation of results, and 
referring for initiation of CPAP when warranted.  Operationalization of an OSA protocol similar 
to the one implemented in this practice can allow APRNs in multiple countries to identify 
patients with OSA, having the potential to improve the lives of patients, families, and 
communities around the world. 
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Appendix A 
Obstructive Sleep Apnea Education Plan for Providers 
Materials: Copy of Clinical Guideline for each provider, patient handout for each provider, copy 
of ESS in both English and Spanish, copy of Project Clinic OSA protocol, copy of a sleep report 
de-identified 
Education: 
1) Screening procedures using ESS 
a. How to fill out form 
b. How to score form  
c. Score of 10 or more equals high risk for OSA 
2) How to refer for a sleep study 
a. Explain to patients risk for OSA  
b. How to schedule a sleep study 
c. Need to schedule follow-up appointment 
3) How to interpret sleep study results 
a. Where to find AHI  
b. Level of OSA: mild, moderate, severe, none 
c. Desaturations 
4) How to explain to patients results 
a. Patient information sheet for reference 
b. Keywords for explanation 
c. Discuss disease progression and treatment options 
5) How to prescribe CPAP 
a. Offer CPAP as choice to patients 
b. How to write auto-titrating prescription 
c. Send task to referral coordinator 
d. Have patient set follow-up appointment  
6) How to conduct a follow-up appointment after CPAP prescribed 
a. Review provider check-list 
b. Discuss how to approach items on checklist 
7)  Importance of routine follow-up 
a. Discuss chronic nature of disease 
b. Patients need to return in 2-6 weeks following CPAP initiation, 3-6 months, then 
on a yearly basis to discuss CPAP usage and OSA progression 
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Appendix B 
 
Epworth Sleepiness Scale 
 
Name: _______________________________________________  Today’s date: ___________________  
 
Your age (yrs): ____________  Your gender (Male = M, Female = F): ____________  
 
 
How likely are you to doze off or fall asleep in the following situations, in contrast to just feeling tired? 
 
This refers to your usual way of life recently. 
 
Even if you haven’t done some of these things recently, try to figure out how they would have affected you. 
 
Use the following scale to choose the most appropriate number for each situation: 
 
0  =  no chance of dozing  
1  =  slight chance of dozing 
2  =  moderate chance of dozing 
3  =  high chance of dozing 
 
It is important that you answer each item as best as you can. 
 
Situation Chance of Dozing (0-3) 
  
  
Sitting and reading   ___________________________________________ ___ 
  
Watching TV   _______________________________________________ ___ 
  
Sitting inactive in a public place (e.g., a theater or a meeting)   __________ ___ 
  
As a passenger in a car for an hour without a break   __________________ ___ 
  
Lying down to rest in the afternoon when circumstances permit   ________ ___ 
  
Sitting and talking to someone   __________________________________ ___ 
  
Sitting quietly after a lunch without alcohol   ________________________ ___ 
  
In a car or bus, while stopped for a few minutes in traffic   _____________ ___ 
  
 
 
 
THANK YOU FOR YOUR COOPERATION 
 
 M.W. Johns  1990-97. Used under License 
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Appendix C 
 
Obstructive Sleep Apnea Protocol 
 
1. Every patient 18 or older that enters the clinic will be given the Epworth 
Sleepiness Scale by the front desk staff in either English or Spanish to complete. 
2.  The medical assistant will obtain the completed form and calculate the score and 
place the score at the top of the form.  
3. The form will be given to the provider by the medical assistant.  
4. Any patient with a score of 10 or more will be referred for a sleep study. 
5. When the sleep study is completed the patient will make an appointment to return 
in 3 weeks for results.  
6. All patients with a positive diagnosis of OSA will be taught sleep hygiene, given 
a patient handout on OSA, and prescribed CPAP.   
7. If the patient accepts a CPAP prescription they will be scheduled for a follow-up 
appointment in approximately one month to discuss CPAP usage and concerns.  
8. A task will be sent to the referral coordinator to initiate CPAP referral to a 
Durable Medical Equipment vendor. 
9. The patient will be called by the MA 2 weeks after a referral is sent for CPAP to 
determine whether the machine and supplies were obtained.  If the machine and 
supplies were obtained the patient will return for their scheduled follow-up 
appointment.   If the machine and supplies were not obtained the DME vendor 
will be contacted by the referral coordinator and the process will begin again and 
a new follow-up appointment will be set after equipment has been received.  
10. After successful initiation of CPAP the patient will return in 2-6 weeks, 3-6 
months, then on a yearly basis to discuss CPAP usage and OSA progression. 
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Appendix D 
Example CPAP prescription 
 
 
 
DX: OSA 
Auto-titrating CPAP 
Pressure Settings 
4-20 cm H2O 
Heated Humidifier 
Mask to fit 
All necessary supplies 
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Appendix E 
Provider Checklist 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
OSA follow-up appointment areas to discuss Discussed 
Present ESS score  
Patient BMI  
Patient sleep related complaints  
Blood Pressure  
Last blood sugar  
Headache  
Pain level  
CPAP usage (how many nights a week)  
CPAP usage (number hours a night)  
Problems with CPAP  
Overall feeling of health   
